GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Total Long-Term Assets

Firebrick Pharma (ASX:FRE) Total Long-Term Assets : A$0.11 Mil (As of Dec. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Firebrick Pharma Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Firebrick Pharma's Total Long-Term Assets for the quarter that ended in Dec. 2023 was A$0.11 Mil.

Firebrick Pharma Total Long-Term Assets Historical Data

The historical data trend for Firebrick Pharma's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Firebrick Pharma Total Long-Term Assets Chart

Firebrick Pharma Annual Data
Trend Jun21 Jun22 Jun23
Total Long-Term Assets
0.09 0.40 0.39

Firebrick Pharma Semi-Annual Data
Jun22 Dec22 Jun23 Dec23
Total Long-Term Assets 0.40 0.40 0.39 0.11

Firebrick Pharma Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Firebrick Pharma Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Firebrick Pharma's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Firebrick Pharma (ASX:FRE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Firebrick Pharma Ltd (ASX:FRE) » Definitions » Total Long-Term Assets
Comparable Companies
XKRX:054300 XKRX:112610 XKRX:378340 XKRX:317830 XKRX:340930 XKRX:372170 XKRX:071670 XKRX:010660 XKRX:058610 XKRX:370090 LLY JNJ MRK ABBV XSWX:ROG LSE:AZN XSWX:NOVN PFE AMGN XPAR:SAN
Traded in Other Exchanges
N/A
Address
440 Collins Street, Level 10, Melbourne, VIC, AUS, 3000
Website
https://www.firebrickpharma.com
Firebrick Pharma Ltd is an Australian pharmaceutical developer. It is engaged in the development and commercialization of Nasodine, a broad-spectrum anti-viral spray, designed to be an effective treatment and prevention of respiratory viral infections such as the common cold.

Firebrick Pharma (ASX:FRE) Headlines

No Headlines